Literature DB >> 28323951

Assessing Energy Requirements in Women With Polycystic Ovary Syndrome: A Comparison Against Doubly Labeled Water.

Nicholas T Broskey1, Monica C Klempel1, L Anne Gilmore1, Elizabeth F Sutton1, Abby D Altazan1, Jeffrey H Burton1, Eric Ravussin1, Leanne M Redman1.   

Abstract

Context: Weight loss is prescribed to offset the deleterious consequences of polycystic ovary syndrome (PCOS), but a successful intervention requires an accurate assessment of energy requirements. Objective: Describe energy requirements in women with PCOS and evaluate common prediction equations compared with doubly labeled water (DLW). Design: Cross-sectional study. Setting: Academic research center. Participants: Twenty-eight weight-stable women with PCOS completed a 14-day DLW study along with measures of body composition and resting metabolic rate and assessment of physical activity by accelerometry. Main Outcome: Total daily energy expenditure (TDEE) determined by DLW.
Results: TDEE was 2661 ± 373 kcal/d. TDEE estimated from four commonly used equations was within 4% to 6% of the TDEE measured by DLW. Hyperinsulinemia (fasting insulin and homeostatic model assessment of insulin resistance) was associated with TDEE estimates from all prediction equations (both r = 0.45; P = 0.02) but was not a significant covariate in a model that predicts TDEE. Similarly, hyperandrogenemia (total testosterone, free androgen index, and dehydroepiandrosterone sulfate) was not associated with TDEE. In weight-stable women with PCOS, the following equation derived from DLW can be used to determine energy requirements: TDEE (kcal/d) = 438 - [1.6 * Fat Mass (kg)] + [35.1 * Fat-Free Mass (kg)] + [16.2 * Age (y)]; R2 = 0.41; P = 0.005. Conclusions: Established equations using weight, height, and age performed well for predicting energy requirements in weight-stable women with PCOS, but more precise estimates require an accurate assessment of physical activity. Our equation derived from DLW data, which incorporates habitual physical activity, can also be used in women with PCOS; however, additional studies are needed for model validation.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28323951      PMCID: PMC5470767          DOI: 10.1210/jc.2017-00459

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  38 in total

1.  Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.

Authors:  Paula Trumbo; Sandra Schlicker; Allison A Yates; Mary Poos
Journal:  J Am Diet Assoc       Date:  2002-11

2.  A Biometric Study of Human Basal Metabolism.

Authors:  J A Harris; F G Benedict
Journal:  Proc Natl Acad Sci U S A       Date:  1918-12       Impact factor: 11.205

3.  Basal metabolic rate in women with PCOS compared to eumenorrheic controls.

Authors:  Sara J Churchill; Erica T Wang; Gaisu Bhasin; Carolyn Alexander; Catherine Bresee; Marita Pall; Ricardo Azziz; Ruchi Mathur; Margareta D Pisarska
Journal:  Clin Endocrinol (Oxf)       Date:  2015-03-05       Impact factor: 3.478

4.  Dietary intake, resting energy expenditure, and eating behavior in women with and without polycystic ovary syndrome.

Authors:  Ingrid Larsson; Lena Hulthén; Mikael Landén; Erik Pålsson; PerOlof Janson; Elisabet Stener-Victorin
Journal:  Clin Nutr       Date:  2015-02-20       Impact factor: 7.324

5.  Statin is a reasonable treatment option for patients with Polycystic Ovary Syndrome: a meta-analysis of randomized controlled trials.

Authors:  L Gao; F-L Zhao; S-C Li
Journal:  Exp Clin Endocrinol Diabetes       Date:  2012-05-25       Impact factor: 2.949

6.  Use of an automated chromium reduction system for hydrogen isotope ratio analysis of physiological fluids applied to doubly labeled water analysis.

Authors:  D A Schoeller; A S Colligan; T Shriver; H Avak; C Bartok-Olson
Journal:  J Mass Spectrom       Date:  2000-09       Impact factor: 1.982

Review 7.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

8.  Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.

Authors:  Nigel K Stepto; Samantha Cassar; Anju E Joham; Samantha K Hutchison; Cheryce L Harrison; Rebecca F Goldstein; Helena J Teede
Journal:  Hum Reprod       Date:  2013-01-12       Impact factor: 6.918

Review 9.  Improving reproductive performance in overweight/obese women with effective weight management.

Authors:  Robert J Norman; Manny Noakes; Ruijin Wu; Michael J Davies; Lisa Moran; Jim X Wang
Journal:  Hum Reprod Update       Date:  2004 May-Jun       Impact factor: 15.610

10.  Consensus on infertility treatment related to polycystic ovary syndrome.

Authors: 
Journal:  Hum Reprod       Date:  2008-03       Impact factor: 6.918

View more
  2 in total

1.  Accuracy of the Resting Energy Expenditure Estimation Equations for Healthy Women.

Authors:  Rafael Molina-Luque; Fernanda Carrasco-Marín; Constanza Márquez-Urrizola; Natalia Ulloa; Manuel Romero-Saldaña; Guillermo Molina-Recio
Journal:  Nutrients       Date:  2021-01-24       Impact factor: 5.717

2.  Dietary and Physical Activity Behaviors in Women with Polycystic Ovary Syndrome per the New International Evidence-Based Guideline.

Authors:  Annie W Lin; Maryam Kazemi; Brittany Y Jarrett; Heidi Vanden Brink; Kathleen M Hoeger; Steven D Spandorfer; Marla E Lujan
Journal:  Nutrients       Date:  2019-11-08       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.